Week In Review: Innovent’s Hong Kong IPO: Raising $422 Million At $2 Billion Valuation

Innovent Biologics of Suzhou plans to raise $422 million in its Hong Kong IPO at a $2 billion valuation, according to multiple media reports (see story). The company, formed in 2011, struck a major $1 …
( read original story …)

---